相似文献
1
Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.
J Med Chem. 2006 Jul 27;49(15):4487-96. doi: 10.1021/jm060363v.
2
Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMR.
Biopolymers. 2008 Dec;89(12):1077-87. doi: 10.1002/bip.21060.
3
Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
J Med Chem. 2003 Dec 18;46(26):5606-18. doi: 10.1021/jm030246p.
4
Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.
J Med Chem. 2005 Jan 27;48(2):523-33. doi: 10.1021/jm049518u.
5
Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
J Med Chem. 2003 Dec 18;46(26):5579-86. doi: 10.1021/jm030243c.
6
Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
J Med Chem. 2003 Dec 18;46(26):5587-96. doi: 10.1021/jm0302445.
7
Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
J Med Chem. 2003 Dec 18;46(26):5597-605. doi: 10.1021/jm030245x.
8
Drug design at peptide receptors: somatostatin receptor ligands.
J Mol Neurosci. 2002 Feb-Apr;18(1-2):15-27. doi: 10.1385/JMN:18:1-2:15.
9
A light-activated beta-turn scaffold within a somatostatin analog: NMR structure and biological activity.
Chem Biol Drug Des. 2006 Feb;67(2):127-36. doi: 10.1111/j.1747-0285.2005.00337.x.
10
Differential effects of somatostatin and angiopeptin on cell proliferation.
Br J Pharmacol. 1998 May;124(2):323-30. doi: 10.1038/sj.bjp.0701843.
引用本文的文献
1
Structural insights into ligand recognition and selectivity of somatostatin receptors.
Cell Res. 2022 Aug;32(8):761-772. doi: 10.1038/s41422-022-00679-x. Epub 2022 Jun 23.
2
The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors.
Molecules. 2021 Dec 30;27(1):210. doi: 10.3390/molecules27010210.
3
DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst Receptors.
Front Chem. 2017 Feb 23;5:8. doi: 10.3389/fchem.2017.00008. eCollection 2017.
4
Peptide aromatic interactions modulated by fluorinated residues: Synthesis, structure and biological activity of Somatostatin analogs containing 3-(3',5'difluorophenyl)-alanine.
Sci Rep. 2016 Jun 7;6:27285. doi: 10.1038/srep27285.
5
The role of brain somatostatin receptor 2 in the regulation of feeding and drinking behavior.
Horm Behav. 2015 Jul;73:15-22. doi: 10.1016/j.yhbeh.2015.05.009. Epub 2015 May 27.
6
Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice.
Peptides. 2015 Jan;63:71-80. doi: 10.1016/j.peptides.2014.10.013. Epub 2014 Nov 5.
7
Brain somatostatin receptor 2 mediates the dipsogenic effect of central somatostatin and cortistatin in rats: role in drinking behavior.
Am J Physiol Regul Integr Comp Physiol. 2014 Oct 1;307(7):R793-801. doi: 10.1152/ajpregu.00248.2014. Epub 2014 Jul 16.
8
Insights into structure-activity relationships of somatostatin analogs containing mesitylalanine.
Molecules. 2013 Nov 25;18(12):14564-84. doi: 10.3390/molecules181214564.
9
Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications.
Front Endocrinol (Lausanne). 2013 Jan 11;3:178. doi: 10.3389/fendo.2012.00178. eCollection 2012.
10
Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.
Peptides. 2013 Apr;42:70-7. doi: 10.1016/j.peptides.2012.12.022. Epub 2012 Dec 31.
本文引用的文献
1
Novel analogues of degarelix incorporating hydroxy-, methoxy-, and pegylated-urea moieties at positions 3, 5, 6 and the N-terminus. Part III.
J Med Chem. 2006 Jun 15;49(12):3536-43. doi: 10.1021/jm060240a.
2
Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.
J Med Chem. 2005 Jan 27;48(2):523-33. doi: 10.1021/jm049518u.
3
Structure of octreotide, a somatostatin analogue.
Acta Crystallogr D Biol Crystallogr. 1995 Jan 1;51(Pt 1):48-59. doi: 10.1107/S0907444994006104.
4
Regulation and function of somatostatin receptors.
J Neurochem. 2004 Jun;89(5):1057-91. doi: 10.1111/j.1471-4159.2004.02402.x.
5
Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
J Med Chem. 2003 Dec 18;46(26):5606-18. doi: 10.1021/jm030246p.
6
Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
J Med Chem. 2003 Dec 18;46(26):5597-605. doi: 10.1021/jm030245x.
7
Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
J Med Chem. 2003 Dec 18;46(26):5587-96. doi: 10.1021/jm0302445.
8
Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
J Med Chem. 2003 Dec 18;46(26):5579-86. doi: 10.1021/jm030243c.
9
Somatostatin receptors.
Biochim Biophys Acta. 2003 Sep 22;1616(1):1-84. doi: 10.1016/s0005-2736(03)00235-9.
10
A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.
J Med Chem. 2003 Jun 5;46(12):2334-44. doi: 10.1021/jm021093t.
Zotero 插件